» Articles » PMID: 38113606

White Blood Cell Subtypes and Neutrophil Extracellular Traps Content As Biomarkers for Stroke Etiology in Acute Ischemic Stroke Clots Retrieved by Mechanical Thrombectomy

Abstract

Background: Lymphocytes, macrophages, neutrophils, and neutrophil extracellular traps (NETs) associate with stroke risk factors and form a thrombus through different mechanisms. We investigated the total WBCs, WBC subtypes and NETs composition in acute ischemic stroke (AIS) clots to identify possible etiological differences that could help us further understand the process of thrombosis that leads to AIS.

Methods: AIS clots from 100 cases each of atherothrombotic (AT), cardioembolic (CE) and cryptogenic stroke etiology were collected per-pass as part of the CÚRAM RESTORE registry of AIS clots. Martius Scarlet Blue stain was used to identify the main histological components of the clots. Immunohistochemical staining was used to identify neutrophils, lymphocytes, macrophages, and NETs patterns. The cellular and histological components were quantified using Orbit Image Analysis software.

Results: AT clots were larger, with more red blood cells and fewer WBCs than CE clots. AT clots had more lymphocytes and cryptogenic clots had fewer macrophages than other etiologies. Most significantly, CE clots showed higher expression of neutrophils and extracellular web-like NETs compared to AT and cryptogenic clots. There was also a significantly higher distribution of web-like NETs around the periphery of the CE clots while a mixed distribution was observed in AT clots.

Conclusion: The difference in neutrophil and NETs expression in clots from different etiologies may provide insight into the mechanism of clot formation.

Citing Articles

C-reactive protein expression in acute ischemic stroke blood clots: Implications for etiology.

Liu W, Sahin C, Guner Sak N, Giraud A, Messina P, Bozsak F Eur Stroke J. 2025; :23969873251315636.

PMID: 39910895 PMC: 11803589. DOI: 10.1177/23969873251315636.


The Role of Neutrophils in Multiple Sclerosis and Ischemic Stroke.

Nowaczewska-Kuchta A, Ksiazek-Winiarek D, Szpakowski P, Glabinski A Brain Sci. 2024; 14(5).

PMID: 38790402 PMC: 11118671. DOI: 10.3390/brainsci14050423.


A promising frontier: targeting NETs for stroke treatment breakthroughs.

Fang H, Bo Y, Hao Z, Mang G, Jin J, Wang H Cell Commun Signal. 2024; 22(1):238.

PMID: 38654328 PMC: 11036592. DOI: 10.1186/s12964-024-01563-4.